AMIX
Autonomix Medical, Inc.
Price Chart
Latest Quote
$2.07
-0.03 (-1.43%)
Current Price
| Previous Close | $2.10 |
| Open | $2.08 |
| Day High | $2.14 |
| Day Low | $2.06 |
| Volume | 35,766 |
Stock Information
| Shares Outstanding | 1.96M |
| Cash Equivalents | $3.46M |
| Net Income | $-16.11M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $4.06M |
| EPS (TTM) | $-39.67 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-1.45M |
| Income | $-16.11M |
| Book/sh | $5.83 |
| Cash/sh | $1.77 |
Financial Ratios
| Quick Ratio | 4.23 |
| Current Ratio | 4.85 |
Returns & Margins
| ROA | -157.81% |
| ROE | -315.99% |
Ownership
| Insider Ownership | 5.73% |
| Institutional Ownership | 2.60% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.28 |
| P/B | 0.35 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $40.80 |
Technical Indicators
| SMA20 | $2.99 |
| SMA50 | $4.05 |
| SMA200 | $6.92 |
| RSI | 2.14 |
| ATR | 0.1689 |
| Shares Float | 918K |
| Short Float | 1.45% |
| Short Ratio | 0.22 |
| Volatility | -0.94 |
| Rel Volume | 0.18 |
Performance History
| Week | -20.69% |
| Month | -45.95% |
| Quarter | -54.70% |
| 6 Months | -73.64% |
| YTD | -81.64% |
| Year | -91.20% |
| 10 Years | -99.90% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $2.07 | 35,766 |
| 2026-10-26 | $2.10 | 158,300 |
| 2026-10-23 | $2.42 | 60,200 |
| 2026-10-22 | $2.50 | 28,000 |
| 2026-10-21 | $2.57 | 15,000 |
| 2026-10-20 | $2.61 | 27,000 |
| 2026-10-19 | $2.65 | 37,900 |
| 2026-10-16 | $2.85 | 31,200 |
| 2026-10-15 | $2.93 | 31,800 |
| 2026-10-14 | $2.90 | 56,400 |
| 2026-10-13 | $3.01 | 30,800 |
| 2026-10-12 | $3.10 | 41,900 |
| 2026-10-09 | $3.11 | 33,100 |
| 2026-10-08 | $3.13 | 87,100 |
| 2026-10-07 | $3.41 | 56,200 |
| 2026-10-06 | $3.47 | 63,300 |
| 2026-10-05 | $3.54 | 133,300 |
| 2026-10-02 | $3.78 | 2,574,700 |
| 2026-10-01 | $3.92 | 133,300 |
| 2026-09-30 | $3.83 | 401,800 |
| 2026-09-29 | $3.75 | 47,500 |
| 2026-09-28 | $3.83 | 74,200 |
About Autonomix Medical, Inc.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
đ° Latest News
No news articles available at the moment. Check back later for updates on AMIX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $0 | $176,000 | $79,000 | $0 |
| Total Expenses | $17,034,000 | $11,588,000 | $7,474,000 | $1,990,000 |
| Net Non Operating Interest Income Expense | $319,000 | $178,000 | $48,000 | $0 |
| Interest Expense Non Operating | $0 | $176,000 | $79,000 | $0 |
| Operating Expense | $17,034,000 | $11,588,000 | $7,474,000 | $1,990,000 |
| General And Administrative Expense | $9,890,000 | $6,863,000 | $5,249,000 | $1,245,000 |
| Other Income Expense | - | - | $-8,000,000 | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-16,715,000 | $-11,410,000 | $-15,426,000 | $-1,990,000 |
| Net Interest Income | $319,000 | $178,000 | $48,000 | $0 |
| Interest Income | $319,000 | $354,000 | $127,000 | $0 |
| Normalized Income | $-16,715,000 | $-11,410,000 | $-7,426,000 | $-1,990,000 |
| Net Income From Continuing And Discontinued Operation | $-16,715,000 | $-11,410,000 | $-15,426,000 | $-1,990,000 |
| Total Operating Income As Reported | $-17,034,000 | $-11,588,000 | $-12,030,000 | $-1,990,000 |
| Net Income Common Stockholders | $-16,715,000 | $-11,410,000 | $-15,426,000 | $-1,990,000 |
| Net Income | $-16,715,000 | $-11,410,000 | $-15,426,000 | $-1,990,000 |
| Net Income Including Noncontrolling Interests | $-16,715,000 | $-11,410,000 | $-15,426,000 | $-1,990,000 |
| Net Income Continuous Operations | $-16,715,000 | $-11,410,000 | $-15,426,000 | $-1,990,000 |
| Pretax Income | $-16,715,000 | $-11,410,000 | $-15,426,000 | $-1,990,000 |
| Interest Income Non Operating | $319,000 | $354,000 | $127,000 | $0 |
| Operating Income | $-17,034,000 | $-11,588,000 | $-7,474,000 | $-1,990,000 |
| Per Share | ||||
| Diluted EPS | $-48.72 | $-135.66 | $-311.22 | $-39.58 |
| Basic EPS | $-48.72 | $-135.66 | $-311.22 | $-39.58 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-16,703,000 | $-11,051,000 | $-7,266,000 | $-1,990,000 |
| Reconciled Depreciation | $12,000 | $183,000 | $81,000 | $0 |
| EBITDA (Bullshit earnings) | $-16,703,000 | $-11,051,000 | $-15,266,000 | $-1,990,000 |
| EBIT | $-16,715,000 | $-11,234,000 | $-15,347,000 | $-1,990,000 |
| Diluted Average Shares | $343,655 | $84,115 | $49,558 | $50,280 |
| Basic Average Shares | $343,655 | $84,115 | $49,558 | $50,280 |
| Diluted NI Availto Com Stockholders | $-16,715,000 | $-11,410,000 | $-15,426,000 | $-1,990,000 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Research And Development | $7,144,000 | $4,725,000 | $2,225,000 | $745,000 |
| Selling General And Administration | $9,890,000 | $6,863,000 | $5,249,000 | $1,245,000 |
| Other Gand A | $9,890,000 | $6,863,000 | $5,249,000 | $1,245,000 |
| Total Unusual Items | - | - | $-8,000,000 | - |
| Total Unusual Items Excluding Goodwill | - | - | $-8,000,000 | - |
| Gain On Sale Of Security | - | - | $-8,000,000 | - |
Fetched: 2026-10-20
Balance Sheet (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $5,895,000 | $8,099,000 | $7,628,000 | $644,000 |
| Total Assets | $7,600,000 | $9,806,000 | $9,407,000 | $865,000 |
| Total Non Current Assets | $19,000 | $197,000 | $16,000 | $0 |
| Non Current Deferred Assets | $0 | $176,000 | $0 | - |
| Current Assets | $7,581,000 | $9,609,000 | $9,391,000 | $865,000 |
| Other Current Assets | $577,000 | $473,000 | $783,000 | - |
| Cash Cash Equivalents And Short Term Investments | $7,004,000 | $9,136,000 | $8,608,000 | $865,000 |
| Cash And Cash Equivalents | $7,004,000 | $9,136,000 | $8,608,000 | $865,000 |
| Cash Financial | - | - | $8,608,000 | $865,000 |
| Debt | ||||
| Total Debt | - | - | $1,002,000 | - |
| Long Term Debt And Capital Lease Obligation | - | - | $1,002,000 | - |
| Long Term Debt | - | - | $1,002,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,705,000 | $1,707,000 | $1,779,000 | $221,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $1,002,000 | $0 |
| Current Liabilities | $1,705,000 | $1,707,000 | $777,000 | $221,000 |
| Payables And Accrued Expenses | $1,112,000 | $1,081,000 | $777,000 | $221,000 |
| Payables | $750,000 | $726,000 | $492,000 | $173,000 |
| Total Tax Payable | $50,000 | $50,000 | - | - |
| Accounts Payable | $700,000 | $676,000 | $492,000 | $173,000 |
| Equity | ||||
| Common Stock Equity | $5,895,000 | $8,099,000 | $7,628,000 | $644,000 |
| Total Equity Gross Minority Interest | $5,895,000 | $8,099,000 | $7,628,000 | $644,000 |
| Stockholders Equity | $5,895,000 | $8,099,000 | $7,628,000 | $644,000 |
| Retained Earnings | $-67,094,000 | $-50,379,000 | $-38,969,000 | $-23,543,000 |
| Other | ||||
| Ordinary Shares Number | $543,302 | $118,906 | $44,871 | $50,280 |
| Share Issued | $543,302 | $118,906 | $44,871 | $50,280 |
| Tangible Book Value | $5,895,000 | $8,099,000 | $7,628,000 | $644,000 |
| Invested Capital | $5,895,000 | $8,099,000 | $8,630,000 | $644,000 |
| Working Capital | $5,876,000 | $7,902,000 | $8,614,000 | $644,000 |
| Total Capitalization | $5,895,000 | $8,099,000 | $8,630,000 | $644,000 |
| Additional Paid In Capital | $72,978,000 | $58,476,000 | $46,596,000 | $24,175,000 |
| Capital Stock | $11,000 | $2,000 | $1,000 | $12,000 |
| Common Stock | $11,000 | $2,000 | $1,000 | $12,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $593,000 | $626,000 | - | - |
| Current Accrued Expenses | $362,000 | $355,000 | $285,000 | $48,000 |
| Net PPE | $19,000 | $21,000 | $16,000 | $0 |
Fetched: 2026-10-20
Cash Flow Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-12,292,000 | $-8,272,000 | $-6,667,000 | $-1,854,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-12,282,000 | $-8,258,000 | $-6,648,000 | $-1,854,000 |
| Cash Flow From Continuing Operating Activities | $-12,282,000 | $-8,258,000 | $-6,648,000 | $-1,854,000 |
| Operating Gains Losses | - | - | $8,000,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-10,000 | $-14,000 | $-19,000 | - |
| Investing Cash Flow | $-10,000 | $-14,000 | $-19,000 | $0 |
| Cash Flow From Continuing Investing Activities | $-10,000 | $-14,000 | $-19,000 | $0 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $3,531,000 | $10,027,000 | $13,706,000 | $675,000 |
| Financing Cash Flow | $10,160,000 | $8,800,000 | $14,410,000 | $675,000 |
| Cash Flow From Continuing Financing Activities | $10,160,000 | $8,800,000 | $14,410,000 | $675,000 |
| Net Other Financing Charges | $4,083,000 | $-1,228,000 | $-1,296,000 | - |
| Net Common Stock Issuance | $3,531,000 | $10,027,000 | $13,706,000 | $675,000 |
| Common Stock Issuance | $3,531,000 | $10,027,000 | $13,706,000 | $675,000 |
| Other | ||||
| End Cash Position | $7,004,000 | $9,136,000 | $8,608,000 | $865,000 |
| Beginning Cash Position | $9,136,000 | $8,608,000 | $865,000 | $2,044,000 |
| Changes In Cash | $-2,132,000 | $528,000 | $7,743,000 | $-1,179,000 |
| Proceeds From Stock Option Exercised | $2,546,000 | $1,000 | $0 | - |
| Net PPE Purchase And Sale | $-10,000 | $-14,000 | $-19,000 | $0 |
| Purchase Of PPE | $-10,000 | $-14,000 | $-19,000 | $0 |
| Change In Working Capital | $-107,000 | $1,240,000 | $79,000 | $136,000 |
| Change In Other Current Assets | $-104,000 | $310,000 | $-478,000 | $9,000 |
| Change In Payables And Accrued Expense | $-3,000 | $930,000 | $557,000 | $127,000 |
| Change In Accrued Expense | $-27,000 | $746,000 | $237,000 | $46,000 |
| Change In Payable | $24,000 | $184,000 | $320,000 | $81,000 |
| Change In Account Payable | $24,000 | $184,000 | $320,000 | $81,000 |
| Other Non Cash Items | $3,732,000 | $101,000 | - | - |
| Stock Based Compensation | $796,000 | $1,628,000 | $618,000 | $0 |
| Depreciation Amortization Depletion | $12,000 | $183,000 | $81,000 | $0 |
| Depreciation And Amortization | $12,000 | $183,000 | $81,000 | $0 |
| Net Income From Continuing Operations | $-16,715,000 | $-11,410,000 | $-15,426,000 | $-1,990,000 |
| Issuance Of Debt | - | $0 | $2,000,000 | $0 |
| Net Issuance Payments Of Debt | - | $0 | $2,000,000 | $0 |
| Net Long Term Debt Issuance | - | $0 | $2,000,000 | $0 |
| Long Term Debt Issuance | - | $0 | $2,000,000 | $0 |
| Gain Loss On Investment Securities | - | - | $8,000,000 | - |
Fetched: 2026-10-20